Stivarga Interactions
There are 232 drugs known to interact with Stivarga (regorafenib), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 98 are major, 129 are moderate, and 5 are minor.
- View all 232 medications that may interact with Stivarga
- View Stivarga alcohol/food interactions (1)
- View Stivarga disease interactions (1)
Most frequently checked interactions
View interaction reports for Stivarga (regorafenib) and the medicines listed below.
- acetaminophen
- Actemra (tocilizumab)
- amlodipine
- Aptivus (tipranavir)
- atorvastatin
- Avastin (bevacizumab)
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Enbrel (etanercept)
- Gleevec (imatinib)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Keppra (levetiracetam)
- levothyroxine
- lisinopril
- Ofev (nintedanib)
- omeprazole
- potassium chloride
- Procysbi (cysteamine)
- Prolia (denosumab)
- Pulmozyme (dornase alfa)
- Ravicti (glycerol phenylbutyrate)
- Soliris (eculizumab)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Tecfidera (dimethyl fumarate)
- Trizivir (abacavir / lamivudine / zidovudine)
- Votrient (pazopanib)
Stivarga alcohol/food interactions
There is 1 alcohol/food interaction with Stivarga (regorafenib).
Stivarga disease interactions
There is 1 disease interaction with Stivarga (regorafenib) which include:
Report options
QR code containing a link to this page
More about Stivarga (regorafenib)
- Stivarga consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
